Annual Retained Earnings
-$1.40 B
-$341.97 M-32.30%
December 31, 2023
Summary
- As of February 7, 2025, RLAY annual retained earnings is -$1.40 billion, with the most recent change of -$341.97 million (-32.30%) on December 31, 2023.
- During the last 3 years, RLAY annual retained earnings has fallen by -$996.35 million (-246.48%).
- RLAY annual retained earnings is now -1126.68% below its all-time high of -$114.18 million, reached on December 31, 2018.
Performance
RLAY Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$1.66 B
-$88.11 M-5.60%
September 1, 2024
Summary
- As of February 7, 2025, RLAY quarterly retained earnings is -$1.66 billion, with the most recent change of -$88.11 million (-5.60%) on September 1, 2024.
- Over the past year, RLAY quarterly retained earnings has dropped by -$345.20 million (-26.21%).
- RLAY quarterly retained earnings is now -777.28% below its all-time high of -$189.48 million, reached on December 31, 2019.
Performance
RLAY Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
RLAY Retained Earnings Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -32.3% | -26.2% |
3 y3 years | -246.5% | -137.3% |
5 y5 years | -1126.7% | - |
RLAY Retained Earnings Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -82.3% | at low | -116.4% | at low |
5 y | 5-year | -639.2% | at low | -777.3% | at low |
alltime | all time | -1126.7% | at low | -777.3% | at low |
Relay Therapeutics Retained Earnings History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | -$1.66 B(+5.6%) |
Jun 2024 | - | -$1.57 B(+6.2%) |
Mar 2024 | - | -$1.48 B(+5.8%) |
Dec 2023 | -$1.40 B(+32.3%) | -$1.40 B(+6.3%) |
Sep 2023 | - | -$1.32 B(+5.3%) |
Jun 2023 | - | -$1.25 B(+8.5%) |
Mar 2023 | - | -$1.15 B(+8.9%) |
Dec 2022 | -$1.06 B | -$1.06 B(+6.8%) |
Sep 2022 | - | -$991.11 M(+9.3%) |
Jun 2022 | - | -$906.93 M(+9.2%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | -$830.15 M(+8.1%) |
Dec 2021 | -$768.10 M(+90.0%) | -$768.10 M(+9.6%) |
Sep 2021 | - | -$700.64 M(+9.5%) |
Jun 2021 | - | -$639.81 M(+43.3%) |
Mar 2021 | - | -$446.41 M(+10.4%) |
Dec 2020 | -$404.23 M(+113.3%) | -$404.23 M(-8.0%) |
Sep 2020 | - | -$439.50 M(+82.3%) |
Jun 2020 | - | -$241.09 M(+12.5%) |
Mar 2020 | - | -$214.37 M(+13.1%) |
Dec 2019 | -$189.48 M(+66.0%) | -$189.48 M |
Dec 2018 | -$114.18 M | - |
FAQ
- What is Relay Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Relay Therapeutics?
- What is Relay Therapeutics annual retained earnings year-on-year change?
- What is Relay Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Relay Therapeutics?
- What is Relay Therapeutics quarterly retained earnings year-on-year change?
What is Relay Therapeutics annual retained earnings?
The current annual retained earnings of RLAY is -$1.40 B
What is the all time high annual retained earnings for Relay Therapeutics?
Relay Therapeutics all-time high annual retained earnings is -$114.18 M
What is Relay Therapeutics annual retained earnings year-on-year change?
Over the past year, RLAY annual retained earnings has changed by -$341.97 M (-32.30%)
What is Relay Therapeutics quarterly retained earnings?
The current quarterly retained earnings of RLAY is -$1.66 B
What is the all time high quarterly retained earnings for Relay Therapeutics?
Relay Therapeutics all-time high quarterly retained earnings is -$189.48 M
What is Relay Therapeutics quarterly retained earnings year-on-year change?
Over the past year, RLAY quarterly retained earnings has changed by -$345.20 M (-26.21%)